2022 annual financial data
Ernexa Therapeutics 2022 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -33,217,000 USD and net income was -24,579,000 USD.
Operating cash flow was -20,976,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -33,217,000 USD
- Net income
- -24,579,000 USD
- Operating cash flow
- -20,976,000 USD